Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D GLICK

Showing results (291-300 of 835) with videos related to

Pageof 84
Sort By:
Research Communications in Chemical Pathology and Pharmacology|September 1, 1973
Depletion of hypothalamic norepinephrine by food deprivation and interaction with D-amphetamineS D Glick, D H Waters, S Milloy
Journal of Pediatric Surgery|October 3, 2019
Litigation involving pediatric surgical conditionsBarrie S Rich, Kevin Shelton, Richard D Glick
Pharmacology & Therapeutics|January 1, 1995
Engineering of human cholinesterases explains and predicts diverse consequences of administration of various drugs and poisonsM Schwarz, D Glick, Y Loewenstein, et al.
The American Journal of Pathology|August 1, 1978
Characterization of feline glomerulonephritis associated with viral-induced hematopoietic neoplasmsA D Glick, R G Horn, M Holscher
Neurochemical Research|November 1, 1996
Cyclazocine revisitedS Archer, S D Glick, J M Bidlack
Biochemistry|March 22, 2001
Thermodynamic basis for sequence-specific recognition of ssDNA by an autoantibodyP C Ackroyd, J Cleary, G D Glick
Journal of Psychiatric Practice|June 30, 2005
A paradigm for treatment of inpatient psychiatric disorders: from asylum to intensive careIra D Glick, W Grady Carter, Rajiv Tandon
Psychiatric Services (Washington, D.C.)|December 31, 2008
CATIE findings revisitedJohn M Davis, Stefan Leucht, Ira D Glick
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 5, 2007
Issues that may determine the outcome of antipsychotic trials: industry sponsorship and extrapyramidal side effectJohn M Davis, Nancy Chen, Ira D Glick
Biochemistry|February 6, 1996
Ligand recognition by anti-DNA autoantibodies. Affinity, specificity, and mode of bindingP C Swanson, C Ackroyd, G D Glick
Pageof 84

Showing results (291-300 of 835) with videos related to

Sort By:
Pageof 84
Research Communications in Chemical Pathology and Pharmacology|September 1, 1973
Depletion of hypothalamic norepinephrine by food deprivation and interaction with D-amphetamineS D Glick, D H Waters, S Milloy
Journal of Pediatric Surgery|October 3, 2019
Litigation involving pediatric surgical conditionsBarrie S Rich, Kevin Shelton, Richard D Glick
Pharmacology & Therapeutics|January 1, 1995
Engineering of human cholinesterases explains and predicts diverse consequences of administration of various drugs and poisonsM Schwarz, D Glick, Y Loewenstein, et al.
The American Journal of Pathology|August 1, 1978
Characterization of feline glomerulonephritis associated with viral-induced hematopoietic neoplasmsA D Glick, R G Horn, M Holscher
Neurochemical Research|November 1, 1996
Cyclazocine revisitedS Archer, S D Glick, J M Bidlack
Biochemistry|March 22, 2001
Thermodynamic basis for sequence-specific recognition of ssDNA by an autoantibodyP C Ackroyd, J Cleary, G D Glick
Journal of Psychiatric Practice|June 30, 2005
A paradigm for treatment of inpatient psychiatric disorders: from asylum to intensive careIra D Glick, W Grady Carter, Rajiv Tandon
Psychiatric Services (Washington, D.C.)|December 31, 2008
CATIE findings revisitedJohn M Davis, Stefan Leucht, Ira D Glick
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 5, 2007
Issues that may determine the outcome of antipsychotic trials: industry sponsorship and extrapyramidal side effectJohn M Davis, Nancy Chen, Ira D Glick
Biochemistry|February 6, 1996
Ligand recognition by anti-DNA autoantibodies. Affinity, specificity, and mode of bindingP C Swanson, C Ackroyd, G D Glick
Pageof 84